California health official Erica S. Pan, an epidemiologist, has recommended suspending a certain batch of Moderna vaccine.
California health official and epidemiologist Erica S. Pan said on Sunday (Jan. 17) that she recommended suspending a certain batch of Moderna vaccine because of an increase in allergic reactions after a community clinic in southern California administered the vaccine to people, causing the California government to stop the vaccine as a matter of urgency.
Forsyth News reported on Jan. 18 that a number of health care facilities in southern California recently distributed a batch of Moderna vaccine code-named “041L20A,” and that nearly 10 people had serious allergic reactions and sought emergency medical treatment within 24 hours after a community clinic injected people with the vaccine.
The California Department of Public Health has announced the suspension of the 041L20A batch of vaccine until the Centers for Disease Control and Prevention (CDC), the U.S. Food and Drug Administration (FDA), and the Modena Corporation complete their investigations.
The report said the batch of 041L20A Modena vaccine, with approximately 330,000 doses, was distributed to 287 health care facilities throughout California.
Norway: Deaths after vaccination not related to vaccine
AFP reports that, according to information from the Norwegian public health department, 33 elderly people who received their first dose of the vaccine have died since the vaccination program began at the end of December last year.
Is there a direct link between the deaths of people and the vaccine? Norwegian Public Health Director Camilla Stoltenberg said that the 13 cases that have been carefully analyzed are all elderly, frail and seriously ill.
“As for the causes, no analysis has been completed yet.” Stoltenberg said an average of 45 people pass away each day in Norwegian nursing homes, “so this doesn’t necessarily mean excess deaths or vaccine-related.”
According to Euronews, the Norwegian Medicines Agency 18 also said it could not rule out adverse reactions to the vaccine, such as fever and nausea, that occurred within the first few days after vaccination. Steinar Madsen, the director of medicine at the agency, has also previously said that “patients should be re-evaluated for vaccination if they are very weak, seriously ill, and in conditions where it is clear that their life expectancy is no longer long.”
Recent Comments